Biologists are trying to balance need for scientific openness with concerns that their research might aid bioterrorists. The outcome of this debate will also shape the way the United States and the world manage such high-impact endeavors as human clinical trials, genetic engineering, and cloning, each of which carries potential benefits and risks.